Articles
Last updated: November 10, 2026
Lawsuits over Nevro’s high-frequency spinal cord stimulators, sold as Senza and HFX, are centralized in MDL 3195 before Judge Haywood S. Gilliam, Jr. in the Northern District of California. The Judicial Panel on Multidistrict Litigation created the proceeding on October 2, 2026. There were 24 cases pending on November 2, 2026, and the lawyers who asked for the MDL told the Panel they represent about 300 potential plaintiffs. Applications to lead the litigation are due November 30, and the court’s first conference is December 18, 2026 in Oakland. No Nevro case has been tried or settled.
Nevro Stimulator Lawsuits at a Glance
- Court: MDL 3195, Northern District of California, Judge Haywood S. Gilliam, Jr.; created October 2, 2026.
- Cases pending: 24 as of November 2, 2026.
- Devices: Senza, Senza II, Senza Omnia and HFX iQ.
- Next dates: leadership applications due November 30, 2026; first conference December 18, 2026 in Oakland.
- Recalls: no FDA-classified recall of a Nevro stimulator.
- Trials and settlements: none.
Which Nevro Stimulators Are Named
Nevro’s systems deliver stimulation at 10,000 hertz, far above the frequency of traditional stimulators, and are marketed as relieving pain without the tingling sensation older devices produce. The lawsuits name the Senza, Senza II and Senza Omnia systems and the newer HFX iQ. Nevro was acquired by Globus Medical in 2025, and Globus is named alongside Nevro in some of the cases.
What the Nevro Lawsuits Allege
The Panel described the common questions as Nevro’s regulatory compliance, whether its sales representatives made false or misleading statements about the devices, and whether the company’s conduct amounted to the unauthorized practice of medicine. Its order records the plaintiffs’ allegation that nearly 250 new stimulator devices were brought to market through supplements to earlier approvals instead of through new applications with new clinical data. Patients describe shocks and burning, leads that migrated, devices that stopped relieving pain or made it worse, new neurological symptoms, and revision and removal surgeries. Nevro denies the allegations.
One fact sets Nevro apart from Boston Scientific and Abbott: none of its spinal cord stimulators has been the subject of an FDA-classified recall. A recall is not required for a claim, but Nevro plaintiffs will have to prove their case without one.
How the Courts Have Ruled in Nevro Cases So Far
Nevro cases were being decided one by one before the MDL existed, and the results show how much turns on the way a complaint is written.
- DiToto v. Nevro, District of Maryland, May 2026. The court denied most of Nevro’s motion to dismiss. It held that claims based on a failure to report adverse events to the FDA were not preempted, and it allowed a claim about the training of the people who handled the device to proceed as ordinary negligence. This is the most favorable stimulator ruling for patients to date.
- A New Mexico case, February 2026. The court dismissed the complaint on preemption grounds but without prejudice, and the patient asked for permission to file an amended complaint.
- A Louisiana case, January 2025. Dismissed without prejudice on the same ground.
The Maryland case and the New Mexico case have both been transferred into the MDL, so Judge Gilliam inherits one decision in each direction. His ruling on preemption will replace them for every Nevro case.
Why the Cases Are in Oakland
Plaintiffs asked for the Northern District of California or, in the alternative, for the cases to join the Boston Scientific MDL in Los Angeles. The Panel chose the Northern District, where Nevro is based and where all twelve cases on the original motion were already assigned to Judge Gilliam, whom the order calls “an experienced transferee judge.” By the time of the ruling there were 23 cases in ten districts. A further order on October 14 flagged two more, from Missouri and Oklahoma, for transfer.
What Happens Next in MDL 3195
| Date | Event |
|---|---|
| Oct. 14, 2026 | Pretrial Order No. 1: discovery and briefing on pending motions stayed |
| Nov. 30, 2026 | Applications for plaintiffs’ lead counsel and steering committee due |
| Dec. 14, 2026 | Responses to leadership applications due |
| Dec. 15, 2026 | Joint case management statement due |
| Dec. 18, 2026 | Initial in-person status conference, federal courthouse, Oakland |
After leadership is appointed, the usual sequence is a master complaint, Nevro’s motion to dismiss on preemption grounds, and orders governing how new cases are filed. There is no direct filing order yet; cases filed in the Northern District of California are coordinated automatically, and cases filed elsewhere are transferred.
Who May Qualify for a Nevro Claim
- You received a permanent Nevro Senza or HFX stimulator.
- Afterward you had shocks or burning, lead migration, loss of therapy or worse pain, a serious infection, or new nerve, bowel or bladder problems.
- You needed revision or removal surgery, hospital care or repeated reprogramming, or were advised to turn the device off.
- Your state’s deadline is open: one year in Tennessee, two in Alabama and Georgia, three in North Carolina, counted from the first sign of trouble.
Nevro Spinal Cord Stimulator Lawsuit FAQs
Is there a Nevro spinal cord stimulator class action?
No. Nevro cases are individual lawsuits coordinated in MDL 3195 in the Northern District of California before Judge Haywood S. Gilliam, Jr. There were 24 pending as of November 2, 2026.
Has Nevro settled any spinal cord stimulator lawsuits?
No. There has been no settlement or verdict in a Nevro stimulator product liability case, and the MDL has not set trial dates.
Has the Nevro HFX or Senza been recalled?
No Nevro spinal cord stimulator has been the subject of an FDA-classified recall. The lawsuits do not depend on a recall.
Is Globus Medical part of the Nevro lawsuits?
Globus Medical acquired Nevro in 2025 and is named as a defendant with Nevro in some cases. The MDL is captioned for Nevro Corporation.
For all four manufacturers, the injuries and the deadlines, see our spinal cord stimulator lawsuit guide and the latest lawsuit update. State guides: Alabama, Georgia, Tennessee, North Carolina. To have a Nevro claim reviewed at no charge, call Fob & Foster Personal Injury Lawyers at (205) 407-6009.
Related Practice Areas
- Spinal Cord Stimulator Lawsuit
- Alabama Spinal Cord Stimulator Lawsuit
- Georgia Spinal Cord Stimulator Lawsuit
- Tennessee Spinal Cord Stimulator Lawsuit
- North Carolina Spinal Cord Stimulator Lawsuit
- Spinal Cord Stimulator Lawsuit Update
- Spinal Cord Stimulator Verdicts and Settlements
- Boston Scientific Infinion CX Lead Recall
- Boston Scientific Spinal Cord Stimulator Lawsuit
- Abbott Spinal Cord Stimulator Lawsuit
- Medtronic Spinal Cord Stimulator Lawsuit
Fob James, IV
Fob James obtained a B.S., in software engineering from Auburn University and then continued his education by getting his J.D. from Vanderbilt University School of Law. After working for a large national firm for several years, Fob found that his passion was fighting for individuals who have been seriously injured or wronged by others. Fob believes that the jury is the great equalizer to the power and influence that large corporations have in society. Many of Fob’s cases are high profile and have been featured in, among others: Bloomberg News, PlanAdvisor, AL.com, PlanSponsor, National Law Review, and BusinessInsider. For his work in obtaining numerous multi-million dollar outcomes for his clients, Fob has been recognized by: National Trial Lawyers Top 100, SuperLawyers Rising Star (2020-2026), Birmingham Business Journal Who’s Who in Law (2023-2025), and TrustAnalytica – Top Personal Injury Lawyers in Alabama.